not tagged
abbott
['congrat']
 first trial to show qol benefit in tr patients. congratulations! i feel we need to approach tr similar to mr. moderate-severe is where treatment should be considered and not wait for severe/torrential. lots of data to unpack in this area
Interventional/Structural Cardiology at Vanderbilt @VUMC_heart. @mayocliniccv trained; Opinions are my own and not the views of my employer